Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 296

Similar articles for PubMed (Select 12507739)

1.

Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II).

Akiskal HS, Hantouche EG, Allilaire JF, Sechter D, Bourgeois ML, Azorin JM, Chatenêt-Duchêne L, Lancrenon S.

J Affect Disord. 2003 Jan;73(1-2):65-74.

PMID:
12507739
2.

Validating the bipolar spectrum in the French National EPIDEP Study: overview of the phenomenology and relative prevalence of its clinical prototypes.

Akiskal HS, Akiskal KK, Lancrenon S, Hantouche EG, Fraud JP, Gury C, Allilaire JF.

J Affect Disord. 2006 Dec;96(3):197-205. Epub 2006 Jul 7.

PMID:
16824616
3.

Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.

Hantouche EG, Akiskal HS, Lancrenon S, Chatenêt-Duchêne L.

J Affect Disord. 2005 Feb;84(2-3):243-9.

PMID:
15708422
4.

Bipolar II with and without cyclothymic temperament: "dark" and "sunny" expressions of soft bipolarity.

Akiskal HS, Hantouche EG, Allilaire JF.

J Affect Disord. 2003 Jan;73(1-2):49-57.

PMID:
12507737
5.

[Frequency and clinical aspects of bipolar II disorder in a French multicenter study: EPIDEP].

Allilaire JF, Hantouche EG, Sechter D, Bourgeois ML, Azorin JM, Lancrenon S, Châtenet-Duchêne L, Akiskal HS.

Encephale. 2001 Mar-Apr;27(2):149-58. French.

PMID:
11407267
6.

Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP).

Hantouche EG, Akiskal HS, Lancrenon S, Allilaire JF, Sechter D, Azorin JM, Bourgeois M, Fraud JP, Châtenet-Duchêne L.

J Affect Disord. 1998 Sep;50(2-3):163-73.

PMID:
9858076
7.

Validating the soft bipolar spectrum in the French National EPIDEP Study: the prominence of BP-II 1/2.

Akiskal HS, Akiskal KK, Lancrenon S, Hantouche E.

J Affect Disord. 2006 Dec;96(3):207-13. Epub 2006 May 2.

PMID:
16647762
8.

Bipolar II disorder : epidemiology, diagnosis and management.

Benazzi F.

CNS Drugs. 2007;21(9):727-40. Review.

PMID:
17696573
9.

Bipolar II and anxious reactive "comorbidity": toward better phenotypic characterization suitable for genotyping.

Akiskal HS, Akiskal KK, Perugi G, Toni C, Ruffolo G, Tusini G.

J Affect Disord. 2006 Dec;96(3):239-47. Epub 2006 Sep 14.

PMID:
16973219
10.

Validating affective temperaments in their subaffective and socially positive attributes: psychometric, clinical and familial data from a French national study.

Akiskal HS, Akiskal K, Allilaire JF, Azorin JM, Bourgeois ML, Sechter D, Fraud JP, Chatenêt-Duchêne L, Lancrenon S, Perugi G, Hantouche EG.

J Affect Disord. 2005 Mar;85(1-2):29-36.

PMID:
15780673
11.
12.

Toward a validation of a new definition of agitated depression as a bipolar mixed state (mixed depression).

Benazzi F, Koukopoulos A, Akiskal HS.

Eur Psychiatry. 2004 Apr;19(2):85-90.

PMID:
15051107
13.

Bipolar II vs. unipolar depression: psychopathologic differentiation by dimensional measures.

Hantouche EG, Akiskal HS.

J Affect Disord. 2005 Feb;84(2-3):127-32.

PMID:
15708409
15.

Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders.

Akiskal HS, Bourgeois ML, Angst J, Post R, Möller H, Hirschfeld R.

J Affect Disord. 2000 Sep;59 Suppl 1:S5-S30. Review.

PMID:
11121824
16.
17.

Antidepressant-induced mania in bipolar patients: identification of risk factors.

Henry C, Sorbara F, Lacoste J, Gindre C, Leboyer M.

J Clin Psychiatry. 2001 Apr;62(4):249-55.

PMID:
11379838
18.

Factor structure of hypomania: interrelationships with cyclothymia and the soft bipolar spectrum.

Hantouche EG, Angst J, Akiskal HS.

J Affect Disord. 2003 Jan;73(1-2):39-47.

PMID:
12507736
20.

Challenging DSM-IV criteria for hypomania: diagnosing based on number of no-priority symptoms.

Benazzi F.

Eur Psychiatry. 2007 Mar;22(2):99-103. Epub 2006 Nov 28.

PMID:
17129709
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk